{
    "clinical_study": {
        "@rank": "16539", 
        "biospec_descr": {
            "textblock": "Whole blood samples will be processed for serum and then evaluated for BK virus DNA"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The objectives of this study is to establish the natural history of BK virus viremia and\n      other possible opportunistic viral pathogens in renal transplants receipients."
        }, 
        "brief_title": "BK Virus Infection (Viremia) Natural History in Renal Transplant Recipients", 
        "completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "BK Virus (BKV) Viremia", 
        "condition_browse": {
            "mesh_term": [
                "Viremia", 
                "Virus Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a Natural History study in renal or renal-pancreas transplant recipients.  In an\n      effort to capture patients early in the course of an evolving BK  virus infection and avoid\n      patients who have already developed evidence of BKV-induced nephropathy (BKVN), this\n      protocol will emphasize the initiation of screening in the early post-transplant period.\n      Patients who have undergone renal or renal/pancreas transplantation within 4 weeks, but not\n      more than 90 day previously, will be asked to participate  and then consented to be enrolled\n      in a Natural History-Surveillance period for up to approximately 24 months. Participants\n      enrolled in this study will provide valuable natural history data regarding BKV viremia, and\n      potentially other viral pathogen, in the post-renal transplant period. Participants will\n      provide blood samples to undergo measurement for plasma BKV DNA by PCR approximately every 6\n      weeks, to be resulted in real time at the UAB Diagnostic Virology Laboratory at UAB."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Renal or renal-pancreas transplant patients who are within 4 weeks and not more than 90\n        days post-transplant with or without qualifying BKV viremia Age greater than or equal to\n        18 years; Provides written informed consent.\n\n        Exclusion Criteria:\n\n        Evidence of proven or suspected BKVN by clinical or pathologic diagnostic criteria Loss of\n        renal graft function Initiation of chronic dialysis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Male and female renal or renal-pancreas transplant  recipients  ages 18 and older at risk\n        for BKV infection"
            }
        }, 
        "enrollment": {
            "#text": "450", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01782209", 
            "org_study_id": "DMID 11-0071"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "BK virus viremia", 
            "renal transplant", 
            "other viral pathogens"
        ], 
        "lastchanged_date": "May 19, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35233"
                    }, 
                    "name": "University of Alabama at Birmingham"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94115"
                    }, 
                    "name": "California Pacific Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80045"
                    }, 
                    "name": "University of Colorado at Denver and HSC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55455"
                    }, 
                    "name": "University of Minnesota"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri"
                    }, 
                    "name": "Washington University, Barnes Jewish Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10032"
                    }, 
                    "name": "Columbia University"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Natural History of Infection Caused by BK Virus (and Other Opportunistic Viral Pathogens) in Renal Transplant Recipients", 
        "overall_official": {
            "affiliation": "University of Birmingham at Alabama", 
            "last_name": "John W Gnann, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "We will measure the number of subjects screened who developes BK viremia within 4 weeks and up to 24 months after renal transplant", 
            "measure": "Incidence of BKV viremia in  the study population of screened renal or renal-pancreas transplant subjects", 
            "safety_issue": "No", 
            "time_frame": "within 4 weeks  and up to 24 months after renal transplant"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01782209"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "We will measure the number of days until BK viremia is diagnosed", 
                "measure": "Time to onset of BK viremia", 
                "safety_issue": "No", 
                "time_frame": "Within 4 weeks  and up to 24 months after renal transplant"
            }, 
            {
                "description": "We will measure the length of time from onset to resolution of BK viremia after renal transplant", 
                "measure": "Duration of BK viremia after diagnosis in renal transplant population", 
                "safety_issue": "No", 
                "time_frame": "Within 4 week up to 24 months after renal transplant"
            }, 
            {
                "description": "We will measure the occurance of increased serum creatinine and record data from pathologic examination of renal allograft", 
                "measure": "Incidence of BKVN in study population", 
                "safety_issue": "No", 
                "time_frame": "Within 4 weeks up to 24 months after renal transplant in study population"
            }, 
            {
                "description": "We will measure the number of BK viral DNA found in plasma laboratory specimens over time after diagnosis of BK viremia in renal transplant study population.", 
                "measure": "Quantitative measurment of BV viremia over time", 
                "safety_issue": "No", 
                "time_frame": "Within 4 weeks up to 24 months after renal transplant"
            }, 
            {
                "description": "We will measure the diagnosis of BK viremia in relations to the immunosuppressant drug, dose, and blood levels over time until resolution of BK viremia", 
                "measure": "Association of BK viremia with immunosupressive therapy (drug, doses, blood concentrations)", 
                "safety_issue": "No", 
                "time_frame": "Within 4 weeks and up to 24 months after renal transplant"
            }, 
            {
                "description": "We will measure the incidence of BK viremia  diagnosis relative to renal transplant study population donor/recipient HLA matching.", 
                "measure": "Association of BK viremia with donor/recipient HLA matching", 
                "safety_issue": "No", 
                "time_frame": "Within 4 weeks and up to 24 months after transplant"
            }, 
            {
                "description": "We will measure the incidence of BK viremia diagnosis  relative to renal transplant study population demographic features (gender, age, ethnicity/race).", 
                "measure": "Association of BK viremis with recipient demographic features", 
                "safety_issue": "No", 
                "time_frame": "Within 4 weeks and up to 24 months after renal transplant"
            }
        ], 
        "source": "University of Alabama at Birmingham", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Alabama at Birmingham", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014", 
        "why_stopped": "This study is being withdrawn from Clinicaltrials.gov because it is not an ACT."
    }
}